TOKYO -- Takeda Pharmaceutical is offering early retirement to sales staff and other workers in Japan as the drugmaker strategically narrows its focus areas and slims down its workforce.
Japanese drug titan targets non-R&D staff in restructuring push

Takeda acquired Irish biotech Shire in a 2019 megadeal. It is now looking to refocus and cut expenses. (Photo by Shihoko Nakaoka)
TOKYO -- Takeda Pharmaceutical is offering early retirement to sales staff and other workers in Japan as the drugmaker strategically narrows its focus areas and slims down its workforce.